| 摘要 |
<p>This invention provides the use of RARη selective agonists for the manufacture of a medicament containing one or more such agonists for the treatment of emphysema and other diseases associated with alveolar damage. In another aspect, this invention provides the use of RAR agonists, preferably a RARη selective agonist for the manufacture of medicaments for promoting tropoelastin gene expression and alveolar matrix repair.</p> |
